These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical presentation of juvenile Huntington disease. Ruocco HH; Lopes-Cendes I; Laurito TL; Li LM; Cendes F Arq Neuropsiquiatr; 2006 Mar; 64(1):5-9. PubMed ID: 16622544 [TBL] [Abstract][Full Text] [Related]
3. Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat. Ruocco HH; Lopes-Cendes I; Li LM; Santos-Silva M; Cendes F Braz J Med Biol Res; 2006 Aug; 39(8):1129-36. PubMed ID: 16906288 [TBL] [Abstract][Full Text] [Related]
5. A patient with early onset Huntington disease and severe cerebellar atrophy. Sakazume S; Yoshinari S; Oguma E; Utsuno E; Ishii T; Narumi Y; Shiihara T; Ohashi H Am J Med Genet A; 2009 Feb; 149A(4):598-601. PubMed ID: 19253382 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat. Ruocco HH; Bonilha L; Li LM; Lopes-Cendes I; Cendes F J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):130-5. PubMed ID: 17615168 [TBL] [Abstract][Full Text] [Related]
7. Neuropathological Comparison of Adult Onset and Juvenile Huntington's Disease with Cerebellar Atrophy: A Report of a Father and Son. Latimer CS; Flanagan ME; Cimino PJ; Jayadev S; Davis M; Hoffer ZS; Montine TJ; Gonzalez-Cuyar LF; Bird TD; Keene CD J Huntingtons Dis; 2017; 6(4):337-348. PubMed ID: 29036832 [TBL] [Abstract][Full Text] [Related]
8. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275 [TBL] [Abstract][Full Text] [Related]
9. Juvenile Huntington disease in an 18-month-old boy revealed by global developmental delay and reduced cerebellar volume. Nicolas G; Devys D; Goldenberg A; Maltête D; Hervé C; Hannequin D; Guyant-Maréchal L Am J Med Genet A; 2011 Apr; 155A(4):815-8. PubMed ID: 21412977 [TBL] [Abstract][Full Text] [Related]
10. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Fennema-Notestine C; Archibald SL; Jacobson MW; Corey-Bloom J; Paulsen JS; Peavy GM; Gamst AC; Hamilton JM; Salmon DP; Jernigan TL Neurology; 2004 Sep; 63(6):989-95. PubMed ID: 15452288 [TBL] [Abstract][Full Text] [Related]
11. Classification of cerebellar atrophy using voxel-based morphometry and SPECT with an easy Z-score imaging system. Nanri K; Koizumi K; Mitoma H; Taguchi T; Takeguchi M; Ishiko T; Otsuka T; Nishioka H; Mizusawa H Intern Med; 2010; 49(6):535-41. PubMed ID: 20228587 [TBL] [Abstract][Full Text] [Related]
12. Cerebellar abnormalities in Huntington's disease: a role in motor and psychiatric impairment? Rees EM; Farmer R; Cole JH; Haider S; Durr A; Landwehrmeyer B; Scahill RI; Tabrizi SJ; Hobbs NZ Mov Disord; 2014 Nov; 29(13):1648-54. PubMed ID: 25123926 [TBL] [Abstract][Full Text] [Related]
14. Hypomyelination with atrophy of the basal ganglia and cerebellum: follow-up and pathology. van der Knaap MS; Linnankivi T; Paetau A; Feigenbaum A; Wakusawa K; Haginoya K; Köhler W; Henneke M; Dinopoulos A; Grattan-Smith P; Brockmann K; Schiffmann R; Blaser S Neurology; 2007 Jul; 69(2):166-71. PubMed ID: 17620549 [TBL] [Abstract][Full Text] [Related]
15. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. Kipps CM; Duggins AJ; Mahant N; Gomes L; Ashburner J; McCusker EA J Neurol Neurosurg Psychiatry; 2005 May; 76(5):650-5. PubMed ID: 15834021 [TBL] [Abstract][Full Text] [Related]
16. Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease. van Bergen JM; Hua J; Unschuld PG; Lim IA; Jones CK; Margolis RL; Ross CA; van Zijl PC; Li X AJNR Am J Neuroradiol; 2016 May; 37(5):789-96. PubMed ID: 26680466 [TBL] [Abstract][Full Text] [Related]
17. Juvenile Huntington disease: CT and MR features. Ho VB; Chuang HS; Rovira MJ; Koo B AJNR Am J Neuroradiol; 1995 Aug; 16(7):1405-12. PubMed ID: 7484624 [TBL] [Abstract][Full Text] [Related]
18. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients. Ribaï P; Nguyen K; Hahn-Barma V; Gourfinkel-An I; Vidailhet M; Legout A; Dodé C; Brice A; Dürr A Arch Neurol; 2007 Jun; 64(6):813-9. PubMed ID: 17562929 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Cerebellar Grey Matter Alterations in Bipolar and Cerebellar Patients: Evidence from Voxel-Based Analysis. Lupo M; Olivito G; Gragnani A; Saettoni M; Siciliano L; Pancheri C; Panfili M; Bozzali M; Delle Chiaie R; Leggio M Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805296 [TBL] [Abstract][Full Text] [Related]
20. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Douaud G; Gaura V; Ribeiro MJ; Lethimonnier F; Maroy R; Verny C; Krystkowiak P; Damier P; Bachoud-Levi AC; Hantraye P; Remy P Neuroimage; 2006 Oct; 32(4):1562-75. PubMed ID: 16875847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]